Yuen, C., Artz, A., Kelly, T., Wu, S., Reder, A., Rezania, K., . . . Bishop, M. (2019). NCMP-08. CLINICAL FEATURES OF CAR T-CELL THERAPY NEUROTOXICITY AS POTENTIAL SURROGATE MARKERS FOR PROGRESSION AND OUTCOME. Neuro Oncol.
Citação norma ChicagoYuen, Carlen, et al. "NCMP-08. CLINICAL FEATURES OF CAR T-CELL THERAPY NEUROTOXICITY AS POTENTIAL SURROGATE MARKERS FOR PROGRESSION AND OUTCOME." Neuro Oncol 2019.
Deismireacht MLAYuen, Carlen, et al. "NCMP-08. CLINICAL FEATURES OF CAR T-CELL THERAPY NEUROTOXICITY AS POTENTIAL SURROGATE MARKERS FOR PROGRESSION AND OUTCOME." Neuro Oncol 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.